BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9389523)

  • 1. The cortical actin cytoskeleton of lactotropes as an intracellular target for the control of prolactin secretion.
    Carbajal ME; Vitale ML
    Endocrinology; 1997 Dec; 138(12):5374-84. PubMed ID: 9389523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular mechanisms involved in dopamine-induced actin cytoskeleton organization and maintenance of a round phenotype in cultured rat lactotrope cells.
    Nguyen B; Carbajal ME; Vitale ML
    Endocrinology; 1999 Aug; 140(8):3467-77. PubMed ID: 10433202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J; Ciofi P; Crowley WR
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF; Liu TC
    J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine withdrawal elicits prolonged calcium rise to support prolactin rebound release.
    Ho MY; Kao JP; Gregerson KA
    Endocrinology; 1996 Aug; 137(8):3513-21. PubMed ID: 8754781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes.
    Livingstone JD; Lerant A; Freeman ME
    Neuroendocrinology; 1998 Sep; 68(3):172-9. PubMed ID: 9734001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP; Nguyen DN; Smith SG; Freeman ME
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentrations of dopamine increase cytosolic calcium in lactotrophs.
    Burris TP; Freeman ME
    Endocrinology; 1993 Jul; 133(1):63-8. PubMed ID: 8391429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
    Kineman RD; Gettys TW; Frawley LS
    J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV; Wang W; Grosvenor CE; Crowley WR
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of prolactin secretion after short term or pulsatile exposure to dopamine in superfused anterior pituitary cell aggregates.
    Denef C; Baes M; Schramme C
    Endocrinology; 1984 Apr; 114(4):1371-8. PubMed ID: 6705740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of myosin II in dopamine-induced reorganization of the lactotroph cell's actin cytoskeleton.
    Vitale ML; Carbajal ME
    J Histochem Cytochem; 2004 Apr; 52(4):517-27. PubMed ID: 15034003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.
    Luque EH; Munoz de Toro M; Smith PF; Neill JD
    Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.